Wilhelm, Johannes G.
Dehling, Marco
Higel, Fabian
Article History
Received: 29 July 2018
Revised: 2 November 2018
Accepted: 13 November 2018
First Online: 26 November 2018
Compliance with ethical standards
:
: Marco Dehling, Johannes G. Wilhelm, and Fabian Higel were employees of the Novartis group of companies which is developing, manufacturing, and marketing biopharmaceutical products when this study was conducted. Marco Dehling and Johannes G. Wilhelm are currently employees of MorphoSys AG, which is developing biopharmaceutical products. Fabian Higel is currently an employee of Boehringer Ingelheim Pharma GmbH & Co. KG, which is developing, manufacturing and marketing biopharmaceutical products.